| Embolic stroke of undetermined source: a systematic review and clinical update RG Hart, L Catanese, KS Perera, G Ntaios, SJ Connolly Stroke 48 (4), 867-872, 2017 | 515 | 2017 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, ... The Lancet 395 (10227), 878-887, 2020 | 468 | 2020 |
| Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non … BK Menon, BH Buck, N Singh, Y Deschaintre, MA Almekhlafi, SB Coutts, ... The Lancet 400 (10347), 161-169, 2022 | 192 | 2022 |
| Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial JS Healey, DJ Gladstone, B Swaminathan, J Eckstein, H Mundl, ... JAMA neurology 76 (7), 764-773, 2019 | 185 | 2019 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 183 | 2018 |
| Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry KS Perera, T Vanassche, J Bosch, M Giruparajah, B Swaminathan, ... International journal of stroke 11 (5), 526-533, 2016 | 142 | 2016 |
| Global survey of the frequency of atrial fibrillation–associated stroke: Embolic Stroke of Undetermined Source Global Registry KS Perera, T Vanassche, J Bosch, B Swaminathan, H Mundl, ... Stroke 47 (9), 2197-2202, 2016 | 95 | 2016 |
| Association between low-dose rivaroxaban with or without aspirin and ischemic stroke subtypes: a secondary analysis of the COMPASS trial KS Perera, KKH Ng, S Nayar, L Catanese, L Dyal, M Sharma, SJ Connolly, ... JAMA neurology 77 (1), 43-48, 2020 | 68 | 2020 |
| Characteristics of recurrent ischemic stroke after embolic stroke of undetermined source: secondary analysis of a randomized clinical trial R Veltkamp, LA Pearce, E Korompoki, M Sharma, SE Kasner, D Toni, ... JAMA neurology 77 (10), 1233-1240, 2020 | 45 | 2020 |
| In-hospital delays for acute stroke treatment delivery during the COVID-19 pandemic AH Katsanos, D de Sa Boasquevisque, MA Al-Qarni, M Shawawrah, ... Canadian Journal of Neurological Sciences 48 (1), 59-65, 2021 | 41 | 2021 |
| Evaluating rates of recurrent ischemic stroke among young adults with embolic stroke of undetermined source: the young ESUS longitudinal cohort study KS Perera, D de Sa Boasquevisque, P Rao-Melacini, A Taylor, A Cheng, ... JAMA neurology 79 (5), 450-458, 2022 | 34 | 2022 |
| Stroke type and severity in patients with subclinical atrial fibrillation: an analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and … KS Perera, M Sharma, SJ Connolly, J Wang, MR Gold, SH Hohnloser, ... American heart journal 201, 160-163, 2018 | 33 | 2018 |
| Statin treatment and cerebral microbleeds: A systematic review and meta-analysis AH Katsanos, VA Lioutas, A Charidimou, L Catanese, KKH Ng, K Perera, ... Journal of the Neurological Sciences 420, 117224, 2021 | 31 | 2021 |
| Predictors of recurrent ischemic stroke in patients with embolic strokes of undetermined source and effects of rivaroxaban versus aspirin according to risk status: the NAVIGATE … RG Hart, RC Veltkamp, P Sheridan, M Sharma, SE Kasner, SI Bangdiwala, ... Journal of Stroke and Cerebrovascular Diseases 28 (8), 2273-2279, 2019 | 31 | 2019 |
| Atrial cardiopathy and nonstenosing large artery plaque in patients with embolic stroke of undetermined source H Kamel, LA Pearce, G Ntaios, DJ Gladstone, K Perera, RO Roine, ... Stroke 51 (3), 938-943, 2020 | 30 | 2020 |
| Frequency and features of embolic stroke of undetermined source in young adults KS Perera, B Swaminathan, R Veltkamp, A Arauz, S Ameriso, ... European stroke journal 3 (2), 110-116, 2018 | 30 | 2018 |
| Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial N Martinez‐Majander, G Ntaios, YY Liu, P Ylikotila, H Joensuu, ... European Journal of Neurology 27 (5), 841-848, 2020 | 29 | 2020 |
| Spontaneous heparin-induced thrombocytopenia presenting as cerebral venous sinus thrombosis G Moores, TE Warkentin, MAM Farooqi, SD Jevtic, MP Zeller, KS Perera Neurology: Clinical Practice 11 (6), e929-e931, 2021 | 27 | 2021 |
| Impaired arterial elastic properties and endothelial glycocalyx in patients with embolic stroke of undetermined source I Ikonomidis, A Frogoudaki, AR Vrettou, I Andreou, L Palaiodimou, ... Thrombosis and haemostasis 119 (11), 1860-1868, 2019 | 24 | 2019 |
| Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: recurrent stroke risk and response to antithrombotic therapy SF Ameriso, P Amarenco, LA Pearce, KS Perera, G Ntaios, W Lang, ... Journal of Stroke and Cerebrovascular Diseases 29 (8), 104936, 2020 | 23 | 2020 |
